ATE229801T1 - Arzneimittel bestehend aus diclofenac - Google Patents

Arzneimittel bestehend aus diclofenac

Info

Publication number
ATE229801T1
ATE229801T1 AT01119117T AT01119117T ATE229801T1 AT E229801 T1 ATE229801 T1 AT E229801T1 AT 01119117 T AT01119117 T AT 01119117T AT 01119117 T AT01119117 T AT 01119117T AT E229801 T1 ATE229801 T1 AT E229801T1
Authority
AT
Austria
Prior art keywords
diclofenac
medicinal product
product consisting
medicinal
product
Prior art date
Application number
AT01119117T
Other languages
English (en)
Inventor
Alberto Reiner
Giorgio Reiner
Original Assignee
Applied Pharma Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Pharma Res filed Critical Applied Pharma Res
Application granted granted Critical
Publication of ATE229801T1 publication Critical patent/ATE229801T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT01119117T 1996-05-17 1997-05-15 Arzneimittel bestehend aus diclofenac ATE229801T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI000992A IT1283029B1 (it) 1996-05-17 1996-05-17 Composizioni farmaceutiche a base di diclofenac

Publications (1)

Publication Number Publication Date
ATE229801T1 true ATE229801T1 (de) 2003-01-15

Family

ID=11374276

Family Applications (2)

Application Number Title Priority Date Filing Date
AT97927045T ATE210976T1 (de) 1996-05-17 1997-05-15 Arzneimittel bestehend aus diclofenac
AT01119117T ATE229801T1 (de) 1996-05-17 1997-05-15 Arzneimittel bestehend aus diclofenac

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT97927045T ATE210976T1 (de) 1996-05-17 1997-05-15 Arzneimittel bestehend aus diclofenac

Country Status (24)

Country Link
EP (2) EP1159960B1 (de)
KR (1) KR100441179B1 (de)
AR (1) AR007165A1 (de)
AT (2) ATE210976T1 (de)
AU (1) AU733083B2 (de)
CA (1) CA2254144C (de)
DE (2) DE69709349T2 (de)
DK (2) DK1159960T3 (de)
EE (1) EE9800400A (de)
ES (2) ES2187489T3 (de)
HK (1) HK1043939B (de)
HR (1) HRP970269A2 (de)
IT (1) IT1283029B1 (de)
LT (1) LT4530B (de)
LV (1) LV12250B (de)
MA (1) MA24183A1 (de)
NZ (1) NZ332655A (de)
PL (1) PL188883B1 (de)
PT (2) PT906092E (de)
SK (1) SK157698A3 (de)
TW (1) TW505525B (de)
WO (1) WO1997044023A1 (de)
YU (1) YU19797A (de)
ZA (1) ZA974270B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687542B2 (en) 1996-05-17 2010-03-30 Kowa Pharmaeuticals America, Inc. Rapidly bioavailable tablet and capsule formulations of diclofenac
DE10207394B4 (de) * 2002-02-21 2007-03-29 Lts Lohmann Therapie-Systeme Ag Geschmacksmaskierte oblatenförmige Arzneizubereitung
WO2005115345A1 (en) 2004-05-28 2005-12-08 Imaginot Pty Ltd Oral therapeutic compound delivery system
JO3352B1 (ar) 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
EP3263117A1 (de) 2005-11-28 2018-01-03 Imaginot Pty Ltd. Abgabesystem für eine orale therapeutische verbindung
US7939561B2 (en) 2006-02-07 2011-05-10 Apr Applied Pharma Research S.A. Blister packaging for acute pain regimens
US7700125B2 (en) 2006-02-07 2010-04-20 Kowa Pharmaceuticals America, Inc. Moisture resistant container systems for rapidly bioavailable dosage forms
CA2771831C (en) * 2009-09-25 2018-03-06 Novartis Ag Oral pharmaceutical composition comprising diclofenac
WO2013156163A1 (en) 2012-04-19 2013-10-24 Glatt Ag Taste-masked pharmaceutical compositions containing diclofenac
WO2016193900A1 (en) * 2015-06-05 2016-12-08 Lupin Limited Compositions of diclofenac acid
IT201700009711A1 (it) 2017-01-30 2018-07-30 Applied Pharma Res Sodium free Diclofenac potassium oral solutions Soluzioni orali di Diclofenac potassico prive di sodio
US11260026B2 (en) 2018-12-14 2022-03-01 Apr Applied Pharma Research Sa Ready to use diclofenac stick packs
BR112022025132A2 (pt) 2020-06-10 2022-12-27 Applied Pharma Res Formulações de diclofenaco à base de açúcar biodisponíveis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3607339A1 (de) * 1986-03-06 1987-09-10 Merck Patent Gmbh Pharmazeutische zubereitung
EP0466650A2 (de) * 1990-07-11 1992-01-15 Warner-Lambert Company Entzündungshemmende Behandlung mit nichtsteroiden Mitteln
DE4120311A1 (de) * 1991-06-20 1992-12-24 Kali Chemie Pharma Gmbh Konservierte pharmazeutische zubereitungen
DE59410143D1 (de) * 1993-09-07 2002-08-01 Gergely Gerhard Modifizierte Kristalle einer festen, essbaren, organischen Säure
BR9507768A (pt) * 1994-05-27 1997-09-02 Farmarc Nederland Bv Composição farmacêutica
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs

Also Published As

Publication number Publication date
LT4530B (lt) 1999-07-26
PL329919A1 (en) 1999-04-26
AU733083B2 (en) 2001-05-03
LV12250B (en) 1999-09-20
EP1159960A1 (de) 2001-12-05
PT906092E (pt) 2002-06-28
EP1159960B1 (de) 2002-12-18
KR100441179B1 (ko) 2004-11-26
DE69709349D1 (de) 2002-01-31
DE69709349T2 (de) 2002-07-25
HRP970269A2 (en) 1998-04-30
KR20000010792A (ko) 2000-02-25
CA2254144C (en) 2007-11-20
EE9800400A (et) 1999-06-15
EP0906092A1 (de) 1999-04-07
PL188883B1 (pl) 2005-05-31
SK157698A3 (en) 2000-11-07
YU19797A (sh) 1999-07-28
AR007165A1 (es) 1999-10-13
ITMI960992A0 (de) 1996-05-17
PT1159960E (pt) 2003-03-31
ATE210976T1 (de) 2002-01-15
HK1043939A1 (en) 2002-10-04
CA2254144A1 (en) 1997-11-27
EP0906092B1 (de) 2001-12-19
DK0906092T3 (da) 2002-04-15
ZA974270B (en) 1998-01-30
WO1997044023A1 (en) 1997-11-27
ITMI960992A1 (it) 1997-11-17
ES2187489T3 (es) 2003-06-16
LV12250A (lv) 1999-04-20
DK1159960T3 (da) 2003-03-31
DE69718077D1 (de) 2003-01-30
TW505525B (en) 2002-10-11
LT98160A (en) 1999-03-25
NZ332655A (en) 2000-04-28
HK1043939B (en) 2003-05-16
AU3167697A (en) 1997-12-09
MA24183A1 (fr) 1997-12-31
IT1283029B1 (it) 1998-04-03
DE69718077T2 (de) 2003-09-11
ES2170396T3 (es) 2002-08-01

Similar Documents

Publication Publication Date Title
ATE248594T1 (de) Irbesartanhaltiges arzneimittel
ATE187063T1 (de) Arzneimittel
FI954402L (fi) Uusi farmaseuttinen tuote
ATE138566T1 (de) Tramadol enthaltendes arzneimittel mit verzögerter wirkstoffabgabe
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
IL111380A0 (en) Potentiation of drug response
DE69900162D1 (de) Arzneimittel enthaltend Oxaliplatin
DE69530325D1 (de) Aerosol-arzneiformulierungen
NO973612L (no) Nytt farmasöytisk preparat
NO20021172L (no) Farmasöytisk sammensetning
ATE367150T1 (de) Arzneimittel
ATE237320T1 (de) Venlafaxinhaltiges arzneimittel mit verlängerter wirkstoffabgabe
EP0823255A4 (de) Sucralfat enthaltendes arzneimittel
ATE229801T1 (de) Arzneimittel bestehend aus diclofenac
NO973610D0 (no) Nytt farmasöytisk preparat
LV11727A (lv) Farmaceitiska kompozicija
ITMI941169A0 (it) Formulazioni farmaceutiche
FI973280A0 (fi) Farmaseuttinen koostumus
NO973611D0 (no) Nytt farmasöytisk preparat
BR9711981A (pt) Produto farmac-utico cristalino
BR9606066A (pt) Composto e formulação farmacêutica
DE69819203D1 (de) Trinkbares arzneimittel
BR9605131A (pt) Composição farmacêutica
ZA948357B (en) Potentiation of drug response

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1159960

Country of ref document: EP